Literature DB >> 10809314

Procalcitonin: THE marker of sepsis?

J L Vincent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809314     DOI: 10.1097/00003246-200004000-00057

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  7 in total

1.  Procalcitonin for antibiotic treatment in intensive care unit patients.

Authors:  Nathalie Layios; Bernard Lambermont
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

Review 2.  Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes.

Authors:  Greg S Martin
Journal:  Expert Rev Anti Infect Ther       Date:  2012-06       Impact factor: 5.091

Review 3.  Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection.

Authors:  Sébastien Gibot; Aurélie Cravoisy
Journal:  Clin Med Res       Date:  2004-08

4.  C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome.

Authors:  Rafael Sierra; Jordi Rello; María Angeles Bailén; Encarnación Benítez; Antonio Gordillo; Cristobal León; Sebastián Pedraza
Journal:  Intensive Care Med       Date:  2004-09-11       Impact factor: 17.440

5.  Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics.

Authors:  João Manoel Silva; Sigrid De Sousa dos Santos
Journal:  J Int AIDS Soc       Date:  2013-01-30       Impact factor: 5.396

6.  Procalcitonin: a reliable marker for the diagnosis of neonatal sepsis.

Authors:  Minoo Adib; Zahra Bakhshiani; Fakhri Navaei; Fereshteh Saheb Fosoul; Salomeh Fouladi; Hamidreza Kazemzadeh
Journal:  Iran J Basic Med Sci       Date:  2012-03       Impact factor: 2.699

7.  The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation.

Authors:  Dejie Gao; Xincan Chen; He Wu; Haidong Wei; Jinling Wu
Journal:  Exp Ther Med       Date:  2017-05-23       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.